🇺🇸 FDA

Drug profile · INN

betamethasone acetate

BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

betamethasone acetate (BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

Key facts

INN betamethasone acetate
Brand BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
Route INJECTION
Formulation INJECTABLE
Originator Regeneron Ireland Designated Activity Company (DAC)

Frequently asked questions

What is betamethasone acetate?

betamethasone acetate (BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

What is the brand name for betamethasone acetate?

BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE is a marketed brand name for betamethasone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of betamethasone acetate?

betamethasone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.